TJ037130: Clinical Trials

1 trial of TJ037130, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow TJ037130: new trials by email Literature Review of TJ037130 trials Research Report on TJ037130

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Safety,Pharmacokinetics,Pharmacodynamics,and Efficacy of TJ037130 in Adult Participants With Advanced Solid Tumors
TJ037130 - Solid Tumor, Metastatic Ovary Cancer
Phase 1RecruitingTJ Biopharma Co., Ltd.1282026-10-302026-10-19

Conditions studied

Endometrial Neoplasms (1)  ·  Ovarian Neoplasms (1)  ·  Stomach Neoplasms (1)

Sponsors

TJ Biopharma Co., Ltd. (1)

Countries

China (1)